MTOR and glioma: Studies indicate that downregulating DANCR can mitigate the impact of Wnt/β-catenin activation on glioma cell proliferation and migration [83]. The PI3K/Akt/mTOR signalling pathway is implicated in tumour cell migration, invasion and angiogenesis.